GPT and metabolic dysfunction-associated steatotic liver disease: Supplementation with omega-3 polyunsaturated fatty acids (PUFAs) could be considered as a therapeutic option in the treatment of NAFLD, because it has been seen that it improves aminotransferase levels—aspartate aminotransferase (AST), alanine aminotransferase (ALT)—and gamma-glutamyl transferase (GGT) [7].